Butler Hospital

Running trials

• Not yet recruiting

  Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide

  NCT07898631· Source

• Enrolling by invitation

  Mindfulness-Based Therapy for Serious Mental Illness

  NCT06880796· Source

• Active, not recruiting

  A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07169578· Phase 3· Source

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Source

• Recruiting

  Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

  NCT06982820· Source

• Recruiting

  A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT06647498· Phase 2/3· Source

• Recruiting

  A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT05552157· Phase 2/3· Source

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Source

• Active, not recruiting

  A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

  NCT06544616· Phase 2· Source

• Active, not recruiting

  EMA-Guided Maintenance TMS for Depression

  NCT06145594· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

  NCT05531656· Phase 2· Source

• Active, not recruiting

  A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

  NCT05738486· Phase 3· Source

• Enrolling by invitation

  Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness

  NCT05703412· Source

• Active, not recruiting

  A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

  NCT05399888· Phase 2· Source

• Active, not recruiting

  Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)

  NCT05269394· Phase 2/3· Source

• Active, not recruiting

  Longitudinal Early-onset Alzheimer's Disease Study Protocol

  NCT03507257· Source

• Active, not recruiting

  Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

  NCT01760005· Phase 2/3· Source

• Recruiting

  Dominantly Inherited Alzheimer Network (DIAN)

  NCT00869817· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease4 recruiting
• Depression3 recruiting
• Schizophrenia3 recruiting
• Bipolar disorder2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Exercise to Augment TMS in Those With Treatment Resistant Depression

  NCT05913401· Source

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Source

• Completed

  Intervention for Comorbid Substance Use and Bipolar Disorders

  NCT04202393· Source

• Terminated

  A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

  NCT04241068· Phase 3· Source

• Completed

  Atlas of Retinal Imaging in Alzheimer's Study

  NCT03862222· Source